Cost of Biologics per Treated Patient across Immune-mediated Inflammatory Disease Indications in a Pharmacy Benefit Management Setting: A Retrospective Cohort Study-Reference-Cited by-同舟云学术

Cost of Biologics per Treated Patient across Immune-mediated Inflammatory Disease Indications in a Pharmacy Benefit Management Setting: A Retrospective Cohort Study

Published:2014-08 Issue:8 Volume:36 Page:1231-1241.e3
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Wu Ning,Lee Yuan-Chi (Daisy),Shah Neel,Harrison David J.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference24 articles.

1. Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution;Kuek;Postgrad Med J,2007

2. Enbrel (etanercept) [prescribing information]. lmmunex Corporation, Thousand Oaks, CA.

3. Orencia (abatacept) [prescribing information]. Princeton, NJ: Bristol-Myers Squibb.

4. Humira (adalimumab) [prescribing information]. Abbott Park, Ill: Abbott Laboratories.

5. Cimzia (certolizumab) [prescribing information]. Smyrna, Ga: UCB Inc.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adherence and persistence in patients with rheumatoid arthritis at an integrated health system specialty pharmacy;Journal of Managed Care & Specialty Pharmacy;2021-07

2. Synergistic Effects of Erzhi Pill Combined With Methotrexate on Osteoblasts Mediated via the Wnt1/LRP5/β-Catenin Signaling Pathway in Collagen-Induced Arthritis Rats;Frontiers in Pharmacology;2020-03-11

3. The Evolving Role of Thiopurines in Inflammatory Bowel Disease;Current Treatment Options in Gastroenterology;2019-11-21

4. Value of the Multibiomarker Disease Activity Score to Predict Remission in RA: What Does the Evidence Show?;The Journal of Rheumatology;2019-05

5. Evaluating Costs of Biologic Drugs for the Treatment of Moderate-to-Severe Psoriasis in the United States;Journal of Psoriasis and Psoriatic Arthritis;2019-04-29